Publicerade rapporter och nyheter

DateTimeSubjectDocuments
3/29/20178:50 AMOncology Venture: Investerare har förbundit sig att teckna ytterligare cirka 5,1 MSEK i Oncology Ventures pågående företrädesemissionSe pressmeddelande - Oncology Venture
3/29/20178:50 AMOncology Venture: Investors have committed to subscribe for a further approximately 5.1 MSEK in Oncology Ventures ongoing rights issueSee press release - Oncology Venture
3/28/20172:30 PMOncology Venture: Oncology Venture inlicensierar 2BBB:s fas 2-produkt 2B3-101 till 2X Oncology Inc:s pipelineSe pressmeddelande - Oncology Venture
3/28/20172:30 PMOncology Venture: Oncology Venture in-licenses 2-BBB's Phase 2 product 2B3-101 for 2X Oncology's pipelineSee press release - Oncology Venture
3/24/201711:45 AMOncology Venture: Oncology Venture utvärderar onkologiläkemedel från Eisai Inc. för inlicensiering till 2X Oncology Inc.Se pressmeddelande - Oncology Venture
3/24/201711:45 AMOncology Venture: Oncology Venture to evaluate Eisai oncology drug for in-license to 2X Oncology Inc.See press release - Oncology Venture
3/21/20173:39 PMOncology Venture: Grönt ljus till Oncology Venture för DRP-fokuserad klinisk studie med APO010 i multipelt myelomLäs som pdf - Oncology Venture
3/21/20173:39 PMOncology Venture: Green light to Oncology Venture for DRP focused clinical APO010 study in Multiple MyelomaRead as pdf - Oncology Venture
3/16/20178:45 AMOncology Venture: Idag inleds teckningstiden i Oncology Venture Sweden AB:s nyemissionSe pressmeddelande - Oncology Venture
3/16/20178:45 AMOncology Venture: Oncology Venture Sweden AB announces start of subscription period of the rights issueSee press release - Oncology Venture
3/15/20172:11 PMOncology Venture: Oncology Venture Sweden AB offentliggör godkännande av passportering av prospektSe pressmeddelande - Oncology Venture
3/15/20172:11 PMOncology Venture: Oncology Venture Sweden AB announces approval on passportation of prospectusSee press release - Oncology Venture
3/14/20173:01 PMOncology Venture: Offentliggörande av prospektSe pressmeddelande - Oncology Venture
3/14/20173:01 PMOncology Venture: Publication of prospectusSee press release - Oncology Venture
3/14/20179:03 AMOncology Venture: Nytt datum för årsstämmaSe pressmeddelande - Oncology Venture
1  2  3  4  5  6  7  8  

  • Mäster Samuelsgatan 42
  • 111 57 Stockholm
  • Telefon: 08 - 511 68 000
  • info(snabel-a)aktietorget(punkt)se